Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
出版年份 2021 全文链接
标题
Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
作者
关键词
-
出版物
Diagnostic Pathology
Volume 16, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-03
DOI
10.1186/s13000-021-01099-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of HER2 Status Before and After Trastuzumab-based Chemotherapy in Patients With Advanced Gastric Cancer
- (2020) TAKASHI KIJIMA et al. ANTICANCER RESEARCH
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ARID1A deficiency and immune checkpoint blockade therapy: From mechanisms to clinical application
- (2020) Guangyuan Hu et al. CANCER LETTERS
- Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
- (2020) Vildan B. Cetintas et al. Journal of Translational Medicine
- Frequent RNF43 mutation contributes to moderate activation of Wnt signaling in colorectal signet-ring cell carcinoma
- (2020) Yaqi Li et al. Protein & Cell
- Molecular Classification of Gastric Cancer among Alaska Native People
- (2020) Holly Martinson et al. Cancers
- Current status of immune checkpoint inhibitors for gastric cancer
- (2020) Koji Kono et al. Gastric Cancer
- PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression
- (2020) Binnari Kim et al. Cancers
- Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein–Barr Virus-associated gastric carcinoma
- (2019) Atsuhito Nakayama et al. PLoS One
- Bridging genomics and phenomics of gastric carcinoma
- (2019) Junhun Cho et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing
- (2019) Takashi Yoshida et al. Gastric Cancer
- Microsatellite instability in mismatch repair and tumor suppressor genes and their expression profiling provide important targets for the development of biomarkers in gastric cancer
- (2019) Renu Verma et al. GENE
- ZFHX3 is indispensable for ERβ to inhibit cell proliferation via MYC downregulation in prostate cancer cells
- (2019) Qingxia Hu et al. Oncogenesis
- Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
- (2019) F Wang et al. ANNALS OF ONCOLOGY
- Novel Therapeutic Approaches for Epstein-Barr Virus Associated Gastric Cancer
- (2019) BYUNG WOOG KANG et al. ANTICANCER RESEARCH
- Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features
- (2019) Jiro Watari et al. Scientific Reports
- Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
- (2019) Hao Chen et al. Frontiers in Immunology
- ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer
- (2019) Lin Li et al. Cells
- Dissection of gastric cancer heterogeneity for precision oncology
- (2019) Shamaine Wei Ting Ho et al. CANCER SCIENCE
- Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types
- (2019) Feng Wang et al. JAMA Oncology
- Clinicopathologic Characteristics of Epstein–Barr Virus-Associated Gastric Cancer Over the Past Decade in Japan
- (2019) Yanagi et al. Microorganisms
- Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer
- (2019) Bi-Cheng Wang et al. MEDICINE
- Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients
- (2019) Julia Maria Tober et al. HUMAN PATHOLOGY
- Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer
- (2018) Yang-Kun Wang et al. Cancer Biomarkers
- Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma
- (2018) Pallavi A Patil et al. HISTOPATHOLOGY
- Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
- (2018) Sang Cheul Oh et al. Nature Communications
- Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR -Amplified Gastroesophageal Adenocarcinoma
- (2018) Steven B. Maron et al. Cancer Discovery
- Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
- (2018) De-Shen Wang et al. GUT
- Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma
- (2018) Willem J. Koemans et al. CANCER LETTERS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Lauren classification and individualized chemotherapy in gastric cancer
- (2016) JUNLI MA et al. Oncology Letters
- Update on Epstein-Barr virus and gastric cancer (Review)
- (2015) AYA SHINOZAKI-USHIKU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Comprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers
- (2013) K. Yoon et al. GENOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started